144 rapport biennal 2008/2009
Publications du personnel du CIRC 2008–2009 Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh R, Dawsey SM (2008). Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17(11):3062-3068. Achatz MI, Hainaut P, Ashton-Prolla P (2009). Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol 10(9):920-925. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, Zandvakili I, Shakeri R, Sotoudeh M, Aghcheli K, Salahi R, Pourshams A, Semnani S, Boffetta P, Dawsey SM, Ghadirian P, Narod SA (2008). Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene 27(9):1290-1296. Akbari MR, Malekzadeh R, Shakeri R, Nasrollahzadeh D, Foumani M, Sun Y, Pourshams A, Sadjadi A, Jafari E, Sotoudeh M, Kamangar F, Boffetta P, Dawsey SM, Ghadirian P, Narod SA (2009). Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res 69(20):7994-8000. Allen NE, Appleby PN, Roddam AW, Tjonneland A, Johnsen NF, Overvad K, Boeing H, Weikert S, Kaaks R, Linseisen J, Trichopoulou A, Misirli G, Trichopoulos D, Sacerdote C, Grioni S, Palli D, Tumino R, Bueno-de-Mesquita HB, Kiemeney LA, Barricarte A, Larranaga N, Sanchez MJ, Agudo A, Tormo MJ, Rodriguez L, Stattin P, Hallmans G, Bingham S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Riboli E, Key TJ (2008). Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 88(6):1567-1575. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjonneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Buenode-Mesquita HB, Kiemeney L, Tagliabue G, Palli D, Vineis P, Tumino R, Trichopoulou A, Kassapa C, Trichopoulos D, Ardanaz E, Larranaga N, Tormo MJ, Gonzalez CA, Quiros JR, Sanchez MJ, Bingham S, Khaw KT, Manjer J, Berglund G, Stattin P, Hallmans G, Slimani N, Ferrari P, Rinaldi S, Riboli E (2008). Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 98(9):1574-1581. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, Panico S, Larranaga N, Pera G, Tormo MJ, Sanchez MJ, Ramon QJ, Ardanaz E, Tjonneland A, Olsen A, Chang-Claude J, Linseisen J, Schulz M, Boeing H, Lundin E, Palli D, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Bingham S, Khaw KT, Bas Bueno-de-Mesquita H, Trichopoulou A, Trichopoulos D, Naska A, Tumino R, Riboli E, Kaaks R (2008). Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 15(2):485-497. Allen NE, Roddam AW, Sieri S, Boeing H, Jakobsen MU, Overvad K, Tjonneland A, Halkjaer J, Vineis P, Contiero P, Palli D, Tumino R, Mattiello A, Kaaks R, Rohrmann S, Trichopoulou A, Zilis D, Koumantaki Y, Peeters PH, Bueno-de-Mesquita HB, Barricarte A, Rodriguez L, Dorronsoro M, Sanchez MJ, Chirlaque MD, Esquius L, Manjer J, Wallstrom P, Ljungberg B, Hallmans G, Bingham S, Khaw KT, Boffetta P, Norat T, Mouw T, Riboli E (2009). A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 125(4):982-987. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de- Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Lacroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW, Jr., Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, Gonzalez CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41(9):986-990. Andersson L, Droller MJ, Adolfsson J, Mansson W, Kirkali Z, Boffetta P, Montironi R, Malmstrom PU, Tribukait B, Grossman HB (2008). Chairmen’s summary. Scand J Urol Nephrol (Supp 218):7-11. Andrew AS, Mason RA, Memoli V, Duell EJ (2009). Arsenic activates EGFR pathway signaling in the lung. Toxicol Sci 109(2):350-357. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G (2009). Cervical cancer screening policies and coverage in Europe. Eur J Cancer 45(15):2649-2658. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008). Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 111(1):167-177. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E (2008). Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284. Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P (2008). Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 123(1):153-160. Arbyn M and Cuzick J (2009). International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention. Cancer Lett 278(1):1-2. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE (2009). How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 125(11):2489-2496. Arbyn M, Ronco G, Meijer CJ, Naucler P (2009). Trials comparing cytology with human papillomavirus screening. Lancet Oncol 10(10):935-936. Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J (2009). Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 13(4):648-659. Ariffin H, Martel-Planche G, Daud SS, Ibrahim K, Hainaut P (2008). Li-Fraumeni syndrome in a Malaysian kindred. Cancer Genet Cytogenet 186(1):49-53. Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins MA, Brown MA, Tavtigian SV, Goldgar DE, Young JP, Spurdle AB (2009). Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Hum Mutat 30(5):757-770. Arrossi S, Ramos S, Paolino M, Sankaranarayanan R (2008). Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina. Reprod Health Matters 16(32):50-58. Aune D, De Stefani E, Ronco A, Boffetta P, Deneo- Pellegrini H, Acosta G, Mendilaharsu M (2009). Lepublications du personnel du circ 2008-2009 145
- Page 1:
Centre international de Recherche s
- Page 6 and 7:
ISBN 978-92-832-0426-8 ISSN 1017-34
- Page 9:
Table des matières Introduction 1
- Page 12 and 13:
Par conséquent, le Centre doit ori
- Page 14 and 15:
HANCE). Le Centre contribue aussi
- Page 16 and 17:
des Sections : Données du Cancer ;
- Page 18 and 19:
Références Didier Colin C’est a
- Page 21 and 22:
Section Données du Cancer (cin) Ch
- Page 23 and 24:
Groupe Biostatistique (bst) Chef Dr
- Page 25 and 26:
tion, il serait donc possible que d
- Page 27 and 28:
Groupe Analyse et Interprétation d
- Page 29 and 30:
Figure 3 Réseau européen des Regi
- Page 31 and 32:
Course on Introduction to Cancer Re
- Page 33 and 34:
women attending cervical cancer scr
- Page 35 and 36:
Groupe Production Epidémiologie de
- Page 37 and 38:
Figure 1. Page extraite de l’Atla
- Page 39 and 40:
era les différents moyens d’asso
- Page 41 and 42:
2) Pays d’Amérique latine à fai
- Page 43:
va C, Holcátová I, Agudo A, Caste
- Page 46 and 47:
Le Volume 100 indique un degré plu
- Page 48 and 49:
El Ghissassi F, Baan R, Straif K, G
- Page 51 and 52:
Groupe Epigénétique (ege) Chef Dr
- Page 53 and 54:
composant invariable Skp1 du comple
- Page 55 and 56:
Groupe Cancérogenèse moléculaire
- Page 57 and 58:
mécanisme rédox-dépendant (Bykov
- Page 59 and 60:
Références et Publications Achatz
- Page 61:
Section Pathologie moléculaire (mp
- Page 64 and 65:
dans les astrocytomes sporadiques.
- Page 66 and 67:
La Section exprime sa gratitude aux
- Page 69 and 70:
Groupe Biologie des Infections et C
- Page 71 and 72:
Prévalence des infections à VPH e
- Page 73 and 74:
Chef Dr Silvia Franceschi Chercheur
- Page 75 and 76:
ces HAART est en effet associée à
- Page 77 and 78:
Edefonti V, Decarli A, La Vecchia C
- Page 79:
C, Pelucchi C, Montella M, Francesc
- Page 82 and 83:
72 rapport biennal 2008/2009
- Page 84 and 85:
Les recherches du Groupe Mode de vi
- Page 86 and 87:
2008). Le Groupe a également termi
- Page 88 and 89:
Chuang SC, Hashibe M, Scelo G, Brew
- Page 90 and 91:
Rayonnements non ionisants Avec la
- Page 93 and 94:
Section Nutrition et Métabolisme (
- Page 95 and 96:
Groupe Evaluation des expositions a
- Page 97 and 98:
dologique est également en prépar
- Page 99 and 100:
Kiemeney LA, Chirlaque MD, Ardanaz
- Page 101 and 102:
ducts, and risk of breast cancer in
- Page 103: Section génétique (gen) Chef Dr P
- Page 106 and 107: Epidémiologie génétique et molé
- Page 108 and 109: Publications Abnet CC, Kamangar F,
- Page 110 and 111: 100 rapport biennal 2008/2009
- Page 112 and 113: Tableau 1. Projet de système de cl
- Page 114 and 115: Références Chaudru V, Lo MT, Lesu
- Page 117 and 118: Groupe Prévention (pre) Chef Dr Ph
- Page 119 and 120: J/cm2 J/cm2 a b Figure 1. Moyenne q
- Page 121 and 122: Publications *Autier P, *Héry C, H
- Page 123 and 124: Groupe Dépistage (scr) Chef Dr R.
- Page 125 and 126: Projet multicentrique sur le vaccin
- Page 127 and 128: Mathur, All India Institute of Medi
- Page 129 and 130: Sankaranarayanan R, Ferlay J (2009)
- Page 131 and 132: Groupe Assurance-Qualité (qas) Che
- Page 133 and 134: fin 2007, 70 programmes de dépista
- Page 135 and 136: Références Perry N, Broeders M, d
- Page 137 and 138: Groupe Communication (com) Chef Dr
- Page 139 and 140: Education et Formation (etr) Dr P.
- Page 141 and 142: nale sur le cancer, ce qui pourrait
- Page 143 and 144: Etude d’intervention contre l’h
- Page 145 and 146: Comité d’éthique du CIRC (ce) E
- Page 147 and 148: Conseils scientifique et de Directi
- Page 149 and 150: Suisse Dr Gérard Escher Secrétari
- Page 151 and 152: Membres du Conseil scientifique (20
- Page 153: Division de l’administration et d
- Page 157 and 158: Boffetta P, Hecht S, Gray N, Gupta
- Page 159 and 160: of major lymphoma subtypes. Occup E
- Page 161 and 162: elative validity of dietary glycaem
- Page 163 and 164: Greenblatt MS, Brody LC, Foulkes WD
- Page 165 and 166: Johansson M, Appleby PN, Allen NE,
- Page 167 and 168: Lopez-Beltran A, Kirkali Z, Cheng L
- Page 169 and 170: M, Moutsiou E, Trichopoulou A, Laur
- Page 171 and 172: J, Johansson I, Ye W, Slimani N, Du
- Page 173 and 174: Spurdle AB, Couch FJ, Hogervorst FB
- Page 175 and 176: Vrieling A, Verhage BA, van Duijnho